Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(13/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(13/week)
News
United States
(626/week)
Manufacturing
(450/week)
Energy
(343/week)
Technology
(477/week)
Other Manufacturing
(372/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Dipeptidyl peptidase-4 inhibitor
Nov 17, 2019
Interim analysis from EMPRISE real-world study shows Jardiance® decreased risk of hospitalization for heart failure compared with DPP-4 inhibitors and GLP-1 receptor agonists
Nov 05, 2019
Global Oral Anti-Diabetic Drugs Market: World Market - Opportunities and Forecast (2019-2024)
Nov 04, 2019
Boehringer Ingelheim and Lilly modernise alliance to focus full expertise on Jardiance®
Jun 11, 2019
Safety of Linagliptin for Adults with Type 2 Diabetes Who Have High Risk of Cardiovascular and/or Renal Disease Examined in CARMELINA
Jun 10, 2019
Linagliptin and Glimepiride Have Comparable Cardiovascular Safety Effects in Type 2 Diabetes at High Cardiovascular Risk
Jun 10, 2019
Detailed findings from CAROLINA® outcome trial support long-term cardiovascular safety profile of Tradjenta®
Jun 04, 2019
U.S. FDA Accepts New Drug Application for Triple Combination Tablet for Adults with Type 2 Diabetes
Nov 05, 2018
Initial results from EMPRISE real-world evidence study show Jardiance® was associated with reduced risk for hospitalization for heart failure compared with DPP-4 inhibitors in people with type 2 diabetes with and without cardiovascular disease
Oct 04, 2018
Boehringer Ingelheim and Lilly present full results of Tradjenta®'s CARMELINA® cardiovascular outcome trial
Sep 20, 2018
Bernstein Liebhard LLP Partner Named to Plaintiffs' Executive Committee for Federal Onglyza Heart Failure Lawsuits
Jul 19, 2018
Boehringer Ingelheim and Lilly announce Tradjenta's CARMELINA® cardiovascular outcome trial meets primary endpoint
Dec 19, 2017
$179.9 Billion Enzyme Inhibitors Markets, 2022
Jun 01, 2017
Boehringer Ingelheim and Lilly Diabetes Alliance to Present 33 Abstracts at the American Diabetes Association's 77th Scientific Sessions®
Latest News
May 7, 2024
Trellix Receives Six Awards for Industry Leadership in Threat Detection and Response
May 7, 2024
92% of CISOs Question the Future of Their Role Amidst Growing AI Pressures
May 7, 2024
Trellix Database Security Safeguards Sensitive Data
May 7, 2024
Hayward Cuts Ribbon on Hayward Hub DFW
May 7, 2024
Otter Tail Corporation Announces First Quarter Earnings and Increases 2024 Annual Earnings Guidance
May 7, 2024
Redwire Selected by Rocket Lab to Provide Antennas for the Space Development Agency’s Transport Layer Tranche...
May 7, 2024
Winners of the Milken-Motsepe Prize in Green Energy Announced During Opening Session of Milken Institute...
May 7, 2024
Black Stone Minerals, L.P. Reports First Quarter Results
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events